AUA
  • Program
  • Register
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
  • Photo Gallery
Topics
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
  • Photo Gallery
Resources
  • Program
  • Register
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
May 22, 2021

UroLift procedure provides rapid relief and recovery for Benign Prostatic Hyperplasia

This treatment option is gaining popularity with patients and urologists.


Benjamin Dehner, MD
Benjamin Dehner, MD

A one-time, in-office procedure that provides symptomatic relief for benign prostatic hyperplasia (BPH) is helping patients get back to their lives and activities at a much faster rate than if they had traditional surgery, according to Benjamin Dehner, MD, chief of urology at St. Thomas West Hospital in Nashville, Tennessee.

The UroLift procedure, which uses tiny metal implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra, has been gaining popularity with patients and urologists since it entered the market about eight years ago, Dr. Dehner said.

He will describe the procedure and its benefits during Saturday’s Sponsored Residents Symposia by NeoTract/Teleflex, “The UroLift Procedure: The Importance of the Largest Group of Patients in All Urology Practice.”Aua Uro Lift

Historically, patients who experienced typical BPH symptoms, including urinary frequency, hesitancy and nighttime urinary frequency (nocturia), had two options for symptom relief. They could begin taking medicine, which could turn into a lifelong treatment, or they could opt for surgery.

“Men were either stuck on medicine indefinitely because they didn’t want to go into surgery or they had surgery and potentially could have some pretty drastic lifestyle modifications, including incontinence or erectile dysfunction,” Dr. Dehner said.

Alternatively, the UroLift System allows for a resolution of symptoms and a return to an improved lifestyle while avoiding risks and concerns involved with a more significant surgical procedure.

Good candidates for the UroLift procedure are men over the age of 45 with prostate sizes that are 100 grams or less, according to Dr. Dehner. “Our best candidates are the ones who are motivated to find something beyond medication to treat their BPH. They really self-select themselves for the procedure.”

Dr. Dehner said he views UroLift as a middle-of-the-road category for men who are dissatisfied with the more traditional treatment options.

“I'm really excited about what I've seen with this technology over the years,” he said. “I've been involved in over 500 cases, so I fully have invested myself. I’m of the belief that we can do better for our patients rather than just sitting back and watching them suffer.”

Visit AUA2021 Daily News Online for more articles.

Interesting Stories
Book your AUA2025 housing now
Sponsored by AUA
Book your AUA2025 housing now
Register for the Career Fair at AUA2025
Sponsored by AUA
Register for the Career Fair at AUA2025
YONSA® (abiraterone acetate) Holds a Full House of Benefits—See Booth 1222
Sponsored by Sun Pharma
YONSA® (abiraterone acetate) Holds a Full House of Benefits—See Booth 1222
More Content
Getty Images 1208851295
AUA2022
Save the date
Jan 31, 2022
Aua Wrap 04
AUA2021
AUA2021 On Demand: see what’s streaming
Sep 22, 2021
Aua Wrap 03
AUA2021
Satellite symposia bring expert insights
Sep 22, 2021
Aua Wrap 01
AUA2021
Education and training for young urologists
Sep 22, 2021
Getty Images 1199215126
AUA2021
Claim your CME
Sep 22, 2021
Aua Wrap 05
AUA2021
Read all about it
Sep 22, 2021
Aua Tv
AUA2021
Must-see TV
Sep 22, 2021
Getty Images 185224486
AUA2021
AUA2021: By the numbers
Sep 15, 2021
Toni K. Choueiri, MD
AUA2021
Late-breaking science
Sep 15, 2021
Ian M. Thompson Jr., MD
AUA2021
Award winners
Sep 15, 2021
Tips And Tricks
AUA2021
Guideline updates
Sep 15, 2021
Ai
AUA2021
New technology
Sep 15, 2021
AUA
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
© 2025 Ascend Media. All rights reserved.